STOCK TITAN

ICON plc (ICLR) CFO gets new RSUs, options and sells shares for taxes

(High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

ICON plc Chief Financial Officer Nigel Bernard John Clerkin reported multiple equity transactions. On August 10, 2026 he exercised 4,293 restricted share units into ordinary shares and received grants of 14,164 new restricted share units and 4,793 stock options with a $166.05 exercise price expiring in 2034. Each restricted share unit converts into one ordinary share at a nominal EUR 0.06 per-share amount deducted from pay. On August 11, 2026 he sold 2,267 ordinary shares in open-market transactions solely to cover tax withholding obligations under a "sell to cover" arrangement, which the company states was not a discretionary trade.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Clerkin Nigel Bernard John
Role Chief Financial Officer
Sold 2,267 shs ($372K)
Approx. gross sale proceeds $372K
Type Security Shares Price Value
Sale Ordinary Shares F4, F5 237 $162.72 $39K
Sale Ordinary Shares F4, F6 259 $163.77 $42K
Sale Ordinary Shares F4, F7 1,591 $164.47 $262K
Sale Ordinary Shares F4, F8 180 $165.51 $30K
Exercise Restricted Share Units F2, F1 918 $0.00 $0.00
Exercise Restricted Share Units F2, F3 3,375 $0.00 $0.00
Grant/Award Restricted Share Units F2, F9 14,164 $0.00 $0.00
Grant/Award Stock Options F10, F11 4,793 $0.00 $0.00
Exercise Ordinary Shares F1, F2 918 -- --
Exercise Ordinary Shares F2, F3 3,375 -- --
Holdings After Transaction: Restricted Share Units — 22,753 shares (Direct); Stock Options — 4,793 shares (Direct); Ordinary Shares — 5,881 shares (Direct)
Footnotes (11)
  1. F1. These restricted share units were granted on March 6, 2025 and (i) 918 restricted share units vested on August 10, 2026, (ii) 918 restricted share units will vest on March 6, 2027, and (iii) 919 restricted share units will vest on March 6, 2028.
  2. F2. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
  3. F3. These restricted share units were granted on May 22, 2025 and (i) 3,375 restricted share units vested on August 10, 2026, (ii) 3,375 restricted share units will vest on March 6, 2027, and (iii) 3,377 restricted share units will vest on March 6, 2028.
  4. F4. The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
  6. F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
  7. F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
  8. F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
  9. F9. These restricted share units were granted on August 10, 2026 and are scheduled to vest in three approximately equal installments on March 8, 2027, March 8, 2028, and March 8, 2029.
  10. F10. These stock options were granted on August 10, 2026 and are scheduled to vest in four approximately equal installments on March 8, 2027, March 8, 2028, March 8, 2029, and March 8, 2030.
  11. F11. The stock options expire on the eighth anniversary of the grant date, subject to automatic extension until the 30th trading day following any period during which trading is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date.
Ordinary shares sold 2,267 shares Open-market sales on August 11, 2026 to cover tax withholding
RSUs exercised 4,293 units Restricted share units converted into ordinary shares on August 10, 2026
New RSUs granted 14,164 units Restricted share units granted August 10, 2026, vesting in three installments
Stock options granted 4,793 options Options on ordinary shares granted August 10, 2026
Option exercise price $166.05 per share Exercise price of stock options granted to the CFO
Option expiration 2034-08-10 Base expiration date, subject to limited automatic extension
RSU nominal conversion price EUR 0.06 per share Par value amount deducted from pay upon RSU vesting
restricted share units financial
"These restricted share units were granted on March 6, 2025 and (i) 918 restricted share units vested"
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
sell to cover financial
"to be funded by a "sell to cover" transaction and does not represent a discretionary"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
foreign private issuer regulatory
"Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b)"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Rule 3a12-3(b) regulatory
"status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act"
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did ICON plc (ICLR) report for CFO Nigel Clerkin?

ICON plc reported that CFO Nigel Clerkin exercised 4,293 restricted share units, received 14,164 new restricted share units and 4,793 stock options, and sold 2,267 ordinary shares in tax-related "sell to cover" transactions.

How many ICON plc (ICLR) shares did the CFO sell, and at what prices?

The CFO sold 2,267 ordinary shares on August 11, 2026 in open-market transactions at weighted average prices within ranges from $162.08 to $166.1599, solely to satisfy tax withholding obligations on vested restricted share units.

What equity awards did ICON plc (ICLR) grant to its CFO on August 10, 2026?

On August 10, 2026, ICON plc granted the CFO 14,164 restricted share units and 4,793 stock options. The options have a per-share exercise price of $166.05 and are scheduled to vest in four approximately equal installments through March 8, 2030.

How do ICON plc (ICLR) restricted share units held by the CFO convert into shares?

Each restricted share unit represents a right to receive one ordinary share upon vesting. A nominal conversion amount equal to the par value, EUR 0.06 per share, is automatically deducted from the CFO’s pay when the units vest.

Were the ICON plc (ICLR) CFO’s August 11, 2026 share sales discretionary?

The company states the August 11, 2026 sales were executed to cover tax withholding obligations arising from vesting and settlement of restricted share units and "do not represent a discretionary transaction" by the CFO.

What is the expiration schedule for the ICON plc (ICLR) CFO’s new stock options?

The CFO’s 4,793 stock options granted August 10, 2026 expire on the eighth anniversary of the grant date, subject to automatic extension during trading blackouts, but in no event later than the tenth anniversary of the grant date.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Clerkin Nigel Bernard John

(Last)(First)(Middle)
C/O ICON PLC
SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN

(Street)
DUBLIND18X5R3

(City)(State)(Zip)

IRELAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
ICON PLC [ ICLR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/10/2026M918A(1)(2)4,773D
Ordinary Shares08/10/2026M3,375A(2)(3)8,148D
Ordinary Shares08/11/2026S(4)237D$162.72(5)7,911D
Ordinary Shares08/11/2026S(4)259D$163.77(6)7,652D
Ordinary Shares08/11/2026S(4)1,591D$164.47(7)6,061D
Ordinary Shares08/11/2026S(4)180D$165.51(8)5,881D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Share Units(2)08/10/2026M918 (1) (1)Ordinary Shares918$01,837D
Restricted Share Units(2)08/10/2026M3,375 (3) (3)Ordinary Shares3,375$06,752D
Restricted Share Units(2)08/10/2026A14,164 (9) (9)Ordinary Shares14,164$014,164D
Stock Options$166.0508/10/2026A4,793 (10)08/10/2034(11)Ordinary Shares4,793$04,793D
Explanation of Responses:
1. These restricted share units were granted on March 6, 2025 and (i) 918 restricted share units vested on August 10, 2026, (ii) 918 restricted share units will vest on March 6, 2027, and (iii) 919 restricted share units will vest on March 6, 2028.
2. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
3. These restricted share units were granted on May 22, 2025 and (i) 3,375 restricted share units vested on August 10, 2026, (ii) 3,375 restricted share units will vest on March 6, 2027, and (iii) 3,377 restricted share units will vest on March 6, 2028.
4. The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
9. These restricted share units were granted on August 10, 2026 and are scheduled to vest in three approximately equal installments on March 8, 2027, March 8, 2028, and March 8, 2029.
10. These stock options were granted on August 10, 2026 and are scheduled to vest in four approximately equal installments on March 8, 2027, March 8, 2028, March 8, 2029, and March 8, 2030.
11. The stock options expire on the eighth anniversary of the grant date, subject to automatic extension until the 30th trading day following any period during which trading is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date.
Remarks:
Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.
/s/ Erina Joan Fox, as Attorney-in-Fact08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)